Evidence map›Paper›PMID 36043101›Full record

ArticleRSC advances2022

Production of

Shiyu Zhu, Xin Cong, Zheng Sun, Zhe Chen, Xu Chen, Zhenzhou Zhu, Shuyi Li, Shuiyuan Cheng

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shiyu ZhuNational R&D Center for Se-rich Agricultural Products Processing, Wuhan Polytechnic University Wuhan 430023 China zhushiyuu@126.com chxu@whpu.edu.cn zhenzhouzhu@126.com lishuyisz@sina.com s-y-cheng@sina.com.ORCID https://orcid.org/0000-0003-1694-5773
Xin CongEnshi Se-Run Material Engineering Technology Co., Ltd Enshi 445000 Hubei China 13905189777@163.com.
Zheng SunCollege of Food Science and Engineering, Wuhan Polytechnic University Wuhan 430023 China sunzheng2013@outlook.com zhechenkwy@163.com.
Zhe ChenCollege of Food Science and Engineering, Wuhan Polytechnic University Wuhan 430023 China sunzheng2013@outlook.com zhechenkwy@163.com.
Xu ChenNational R&D Center for Se-rich Agricultural Products Processing, Wuhan Polytechnic University Wuhan 430023 China zhushiyuu@126.com chxu@whpu.edu.cn zhenzhouzhu@126.com lishuyisz@sina.com s-y-cheng@sina.com.
Zhenzhou ZhuNational R&D Center for Se-rich Agricultural Products Processing, Wuhan Polytechnic University Wuhan 430023 China zhushiyuu@126.com chxu@whpu.edu.cn zhenzhouzhu@126.com lishuyisz@sina.com s-y-cheng@sina.com.ORCID https://orcid.org/0000-0002-3735-7922
Shuyi LiNational R&D Center for Se-rich Agricultural Products Processing, Wuhan Polytechnic University Wuhan 430023 China zhushiyuu@126.com chxu@whpu.edu.cn zhenzhouzhu@126.com lishuyisz@sina.com s-y-cheng@sina.com.ORCID https://orcid.org/0000-0002-8658-155X
Shuiyuan ChengNational R&D Center for Se-rich Agricultural Products Processing, Wuhan Polytechnic University Wuhan 430023 China zhushiyuu@126.com chxu@whpu.edu.cn zhenzhouzhu@126.com lishuyisz@sina.com s-y-cheng@sina.com.
Wuhan Polytechnic University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymatic synthesis of selenium (Se)-enriched peptides is vital for their application in supplementing organic Se. However, the poor stability and reusability of the free enzyme impedes the reaction. In this work, a highly stable immobilized Alcalase was synthesized by immobilizing Alcalase on tannic acid (TA) and polyethyleneimine (PEI) modified Fe

Identifiers

PMID36043101
PMCPMC9364077
OpenAlexW4293900973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.